OBIO
Orchestra BioMed Holdings Inc.
6.00$
+3.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.7% | 93.6% | 92.5% | 91.8% | 91.0% | 90.8% | 87.9% | 83.8% | 93.3% | 94.0% | 95.6% | 96.1% | |
| 16.4% | 32.1% | 28.2% | 32.8% | 34.0% | 29.2% | 31.1% | 43.8% | 40.1% | 30.2% | 28.2% | 17.7% | |
| 93.5% | 92.0% | 90.8% | 90.1% | 88.9% | 87.7% | 84.5% | 79.2% | 91.4% | 92.7% | 93.8% | 95.0% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.1% | 0.2% | 0.2% | 0.0% | 0.1% | 0.1% | 0.0% | |
| 0.1% | 0.2% | 0.1% | 0.1% | 0.3% | 0.2% | 0.2% | 0.4% | 0.3% | 0.3% | 0.3% | 0.2% | |
| 31.5% | 28.5% | 30.8% | 39.0% | 38.6% | 56.7% | 71.5% | 99.3% | 58.3% | 44.8% | 49.4% | 74.6% | |
| 18.5% | 11.8% | 12.6% | 20.0% | 21.5% | 21.3% | 26.2% | 39.8% | 19.7% | 14.6% | 13.6% | 11.6% | |
| 8.9% | 0.7% | 0.6% | 0.5% | 0.5% | 0.7% | 1.0% | 1.5% | 0.7% | 0.7% | 0.8% | 0.7% | |
| 2.7% | 3.0% | 4.1% | 8.7% | 6.3% | 6.7% | 9.4% | 12.4% | 8.1% | 5.3% | 6.3% | 5.3% | |
| – | – | – | – | – | 18.8% | 24.3% | 33.6% | 13.6% | 12.4% | 14.2% | 30.1% | |
| 68.5% | 71.5% | 69.2% | 61.0% | 61.4% | 43.3% | 28.5% | 0.7% | 41.7% | 55.2% | 50.6% | 25.4% | |
| -202.9% | -261.4% | -317.5% | -384.5% | -390.0% | -406.8% | -556.5% | -812.6% | -351.9% | -315.7% | -380.8% | -351.8% | |
| 30.3% | 37.6% | 43.3% | 49.5% | 49.9% | 50.0% | 64.7% | 89.7% | 49.8% | 43.5% | 62.3% | 55.2% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.